Highlights and Quick Summary
- EPS Growth (diluted) for the quarter ending October 31, 2022 was 56.25% (a -120.52% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (diluted) increased by 27.29%
- Annual EPS Growth (diluted) for 2022 was -1822.22% (a -1954.49% decrease from previous year)
- Annual EPS Growth (diluted) for 2021 was 98.26% (a 205.34% increase from previous year)
- Annual EPS Growth (diluted) for 2020 was 32.18% (a 48.77% increase from previous year)
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (diluted) of BRIACELL THERAP
Most recent EPS Growth (diluted)of BCTX including historical data for past 10 years.Interactive Chart of EPS Growth (diluted) of BRIACELL THERAP
BRIACELL THERAP EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 56.25% | -274.14% | 21.95% | 44.19% | -1822.22% |
| 2021 | – | 72.41% | 169.05% | 79.4% | 98.26% |
| 2020 | 99.92% | 80.86% | 72.28% | 34.33% | 32.18% |
| 2019 | -18100.18% | 50.0% | 0.0% | 0.0% | 21.63% |
| 2018 | 0.0% | -100.0% | 0.0% | 0.0% | -60.56% |
| 2017 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2016 | 0.0% | 100.0% | 100.0% | 0.0% | 20.09% |
| 2015 | 0.0% | – | – | – | – |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology